By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the injectable opioid agonist treatment (iOAT) models of care currently operating in Canada,
2) identify the key stakeholders and what pre-implementation consultation is required when starting an iOAT program,
3) describe the key staffing activities required in the provision of iOAT, and
4) incorporate patient perspective into care provision.
Operationalizing Injectable Opioid Agonist Treatment (iOAT)
Past Session
Tuesday, October 26 2021, 12:00pm to 1:00pm PT
Presented by Dr. Marie-Ève Goyer, Dr. Michael Trew, and Stacey Whitman